Please assess the completion status of the following clinical trial:

Trial Title: Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults 18 years of age or greater~* Intention to treat with vasopressor for diagnosis of septic shock~* Exclusion criteria not met~Exclusion Criteria:~* Emergent indication for surgery~* Patient possesses a terminal condition for which patient or medical decision maker has decided to de-escalate medical care (patients with Do Not Resuscitate order but for whom standard care is continued will not be excluded)~* Known allergy to phenylephrine or norepinephrine~* Treated with vasopressor \>12 hours for current episode of shock~* Preference of specific vasopressor agent by patient's provider~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Phenylephrine (Type: ACTIVE_COMPARATOR): Phenylephrine will be administered as the primary vasopressor for the treatment of septic shock
- Norepinephrine (Type: ACTIVE_COMPARATOR): Norepinephrine will be administered as the primary vasopressor for the treatment of septic shock

Based on this trial design, predict the completion outcome and termination type (if applicable).